loading
Schlusskurs vom Vortag:
$0.812
Offen:
$0.82
24-Stunden-Volumen:
43,643
Relative Volume:
0.29
Marktkapitalisierung:
$16.30M
Einnahmen:
$6.56M
Nettoeinkommen (Verlust:
$-14.92M
KGV:
-1.6091
EPS:
-0.54
Netto-Cashflow:
$-33.87M
1W Leistung:
+45.54%
1M Leistung:
+57.98%
6M Leistung:
+41.28%
1J Leistung:
-0.90%
1-Tages-Spanne:
Value
$0.7942
$0.8799
1-Wochen-Bereich:
Value
$0.582
$0.8799
52-Wochen-Spanne:
Value
$0.334
$1.65

Sol Gel Technologies Ltd Stock (SLGL) Company Profile

Name
Firmenname
Sol Gel Technologies Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
36
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
SLGL's Discussions on Twitter

Vergleichen Sie SLGL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SLGL
Sol Gel Technologies Ltd
0.868 16.30M 6.56M -14.92M -33.87M -0.54
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
501.80 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.47 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
629.64 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
258.54 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
248.31 24.70B 3.81B -644.79M -669.77M -6.24

Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-08-19 Herabstufung Raymond James Strong Buy → Outperform
2022-10-21 Fortgesetzt Jefferies Hold
2019-12-31 Bestätigt H.C. Wainwright Buy
2019-12-31 Bestätigt JMP Securities Mkt Outperform

Sol Gel Technologies Ltd Aktie (SLGL) Neueste Nachrichten

pulisher
Apr 25, 2025

Basal Cell Nevus Syndrome Treatment Market 2032: EMA, PDMA, FDA - openPR.com

Apr 25, 2025
pulisher
Apr 22, 2025

Sol-Gel Technologies Ltd [SLGL] Investment Guide: What You Need to Know - knoxdaily.com

Apr 22, 2025
pulisher
Apr 22, 2025

Did Sol-Gel Technologies Ltd (SLGL) perform well in the last session? - uspostnews.com

Apr 22, 2025
pulisher
Apr 17, 2025

Sol-Gel secures $16 million, extends cash runway By Investing.com - Investing.com Canada

Apr 17, 2025
pulisher
Apr 17, 2025

Sol-Gel Technologies Secures $16 Million Deal with Mayne Pharma for U.S. Rights to EPSOLAY and TWYNEO - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Sol-Gel secures $16 million, extends cash runway - Investing.com Australia

Apr 17, 2025
pulisher
Apr 17, 2025

Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S. - The Manila Times

Apr 17, 2025
pulisher
Apr 17, 2025

Sol-Gel's Strategic Pivot: $16M Product Sale Funds Promising Cancer Drug Development - Stock Titan

Apr 17, 2025
pulisher
Apr 13, 2025

XBiotech Inc. (NASDAQ:XBIT) Shares Sold by American Century Companies Inc. - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

Raymond James Financial Inc. Invests $101,000 in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

Raymond James Financial Inc. Purchases New Shares in Stereotaxis, Inc. (NYSEAMERICAN:STXS) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

American Century Companies Inc. Sells 20,635 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Sol-Gel Technologies Ltd. (4SG.F) latest stock news and headlines - Yahoo

Apr 12, 2025
pulisher
Apr 11, 2025

Investors Don't See Light At End Of Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Tunnel And Push Stock Down 31% - simplywall.st

Apr 11, 2025
pulisher
Apr 04, 2025

Acne Vulgaris Market to Reach New Heights in Growth by 2034, - openPR.com

Apr 04, 2025
pulisher
Apr 01, 2025

Sol-Gel Technologies Approves Reverse Share Split and Compensation Policy Renewal - TipRanks

Apr 01, 2025
pulisher
Mar 30, 2025

(PDF) NaFePO4 Particles as a Cathode of Sodium Ion-Battery via Sol-Gel Method: A Review on Synthesis - ResearchGate

Mar 30, 2025
pulisher
Mar 12, 2025

Acne Market on Track for Major Expansion by 2032, According to DelveInsight | Clinuvel Pharma, Novan, Dermata Therapeutics, ioPharmX, Bausch Health Americas, Inc., Kintor Pharma, Sol-Gel Technologies - Barchart

Mar 12, 2025
pulisher
Mar 12, 2025

Acne Market on Track for Major Expansion by 2032, According - openPR

Mar 12, 2025
pulisher
Mar 07, 2025

Sol Gel Technologies Ltd expected to post a loss of 11 cents a shareEarnings Preview - TradingView

Mar 07, 2025
pulisher
Mar 07, 2025

Actinic Keratosis Market Forecast 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Treatment, Medication, Therapies, and Companies by DelveInsight - The Globe and Mail

Mar 07, 2025
pulisher
Mar 07, 2025

Retinoic Acid Receptor Alpha Market Unlocking Growth Opportunities Through Smart Solutions - expressvartha.in

Mar 07, 2025
pulisher
Mar 05, 2025

Uremic Pruritus Clinical and Non-Clinical Studies, Key - openPR

Mar 05, 2025
pulisher
Mar 05, 2025

Sol-Gel Technologies (SLGL) to Release Quarterly Earnings on Wednesday - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Key Driver Transforming The Rosacea Market 2025: Rising Skin Disease Prevalence Fuels Growth In The Rosacea... - WhaTech

Mar 04, 2025
pulisher
Mar 03, 2025

Acne Market Predicted to See Upsurge Through 2032, Highlights - openPR

Mar 03, 2025
pulisher
Mar 03, 2025

Palmoplantar Keratoderma Clinical and Non-Clinical Studies, - openPR

Mar 03, 2025
pulisher
Feb 28, 2025

Sol-Gel Coatings Market Trends, Insights, and Opportunities through 2032 - newstrail.com

Feb 28, 2025
pulisher
Feb 27, 2025

Personalis (PSNL) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Feb 27, 2025
pulisher
Feb 27, 2025

SLGL Gears Up to Report Q4 Earnings: Here's What You Should Know - MSN

Feb 27, 2025
pulisher
Feb 25, 2025

Supernus Pharmaceuticals (SUPN) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance

Feb 25, 2025
pulisher
Feb 18, 2025

Sol-Gel Technologies Schedules Shareholder Meeting to Vote on Key Proposals - TipRanks

Feb 18, 2025
pulisher
Feb 18, 2025

Basal Cell Nevus Syndrome Treatment Market Size in the 7MM - openPR

Feb 18, 2025
pulisher
Feb 11, 2025

Biotech Stocks Facing FDA Decision In August 2021 - RTTNews

Feb 11, 2025
pulisher
Feb 07, 2025

Sol-Gel Technologies Ltd (SLGL) Shares Decline Despite Market Challenges - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Not Doing Enough For Some Investors As Its Shares Slump 51% - Simply Wall St

Feb 07, 2025
pulisher
Feb 07, 2025

Is Sol-Gel Technologies (NASDAQ:SLGL) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Feb 07, 2025
pulisher
Feb 07, 2025

Constellium SE’s (CSTM) Stock: A -3.86% Simple Moving Average for the Past 20 Days - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Tronox Holdings plc (TROX): A Technical Analysis - The News Heater

Feb 07, 2025
pulisher
Feb 06, 2025

PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease - Yahoo Finance

Feb 06, 2025
pulisher
Feb 04, 2025

Rosacea Clinical Trials Analysis 2025: EMA, PDMA, FDA - openPR

Feb 04, 2025
pulisher
Feb 04, 2025

Appointment of Dr. Bryan Jones as an Advisor to Lead Sol-Gel Special Projects - Yahoo Finance

Feb 04, 2025
pulisher
Feb 03, 2025

Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews

Feb 03, 2025
pulisher
Jan 27, 2025

Acne Vulgaris Market Size to Reach USD 10.4 Billion by 2035, with a Growth Rate (CAGR) of 3.33% during 2025-2035 - BioSpace

Jan 27, 2025
pulisher
Jan 21, 2025

(PDF) Synthesis and Characterization of CZTS Thin Films by Sol-Gel Method without Sulfurization - ResearchGate

Jan 21, 2025
pulisher
Jan 14, 2025

Rosacea Pipeline Analysis, Clinical Trials, EMA, PDMA, FDA - openPR

Jan 14, 2025
pulisher
Jan 13, 2025

Actinic Keratosis Treatment Market 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Medication, Therapies, and Companies by DelveInsight - The Globe and Mail

Jan 13, 2025
pulisher
Jan 13, 2025

Acne Vulgaris Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, MOA, ROA by DelveInsight | Dermata Therapeutics, AstraZeneca, Novartis, UCB Pharma, Incyte Inc., Galderma - The Globe and Mail

Jan 13, 2025
pulisher
Jan 13, 2025

Pre-market Movers: AVGR, TIVC, ATNF, SLGL... - RTTNews

Jan 13, 2025
pulisher
Jan 09, 2025

DFD-29: The Journey to FDA Approval and a New Era in Rosacea Management - Dermatology Times

Jan 09, 2025
pulisher
Jan 08, 2025

Acne Vulgaris Market Expected to Experience Major Growth by 2034, According to DelveInsight - EIN News

Jan 08, 2025

Finanzdaten der Sol Gel Technologies Ltd-Aktie (SLGL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.90
price up icon 1.36%
$69.80
price up icon 0.31%
$32.42
price down icon 0.60%
$24.00
price up icon 0.25%
$103.85
price down icon 0.51%
biotechnology ONC
$249.09
price down icon 0.47%
Kapitalisierung:     |  Volumen (24h):